美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06667 美因基因

休市中 10-30 15:30:44

7.075

+0.120

+1.73%

最高7.120	最低6.750	成交量4,400
今开7.120	昨收6.955	日振幅5.32%
总市值15.57亿	流通市值15.57亿	总股本2.20亿
成交额3.07万	换手率0.00%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":7.075,"timestamp":1793345444718,"preClose":6.955,"halted":0,"volume":4400,"delay":0,"changeRate":0.017253774263120074,"floatShares":220000000,"shares":220000000,"eps":0.136851,"marketStatus":"休市中","change":0.12,"latestTime":"10-30 15:30:44","open":7.12,"high":7.12,"low":6.75,"amount":30720,"amplitude":0.053199,"askPrice":7.08,"askSize":200,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":7,"adr":0,"listingDate":1655827200000,"exchange":"SEHK","adjPreClose":6.955,"dividendRate":0.024946,"openAndCloseTimeList":[[1793323800000,1793332800000],[1793336400000,1793347200000]],"volumeRatio":0.10027347308562592,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06667","defaultTab":"news","newsList":[{"id":"2679285095","title":"美因基因：与美年大健康签订2024年美年框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2679285095","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679285095?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:04","pubTimestamp":1793282640,"startTime":"0","endTime":"0","summary":"南财智讯10月29日电，美因基因（06667.HK）公告，公司建议修订2024年美年框架协议项下截至2026年12月31日止年度的年度上限，由人民币2.535亿元增加至人民币3.8亿元。该协议主要涉及公司向美年大健康及其联系人提供检测服务、配套服务及相关产品的交易。此次修订旨在配合2026年剩余期间的预期交易金额，满足业务需求并维持长期合作关系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610293914943635.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610293914943635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190992164","title":"美因基因回购600股股份，耗资约4192港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190992164","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190992164?lang=zh_cn&edition=full","pubTime":"2026-10-27 20:23","pubTimestamp":1793103785,"startTime":"0","endTime":"0","summary":"2026年10月27日，美因基因有限公司发布公告，披露当日在香港联交所场内回购公司股份，共计回购600股，占当日前已发行股本约0.0003%，最高回购价为每股6.99港元，最低回购价为每股6.985港元，总耗资约4192港元。公告同时显示，美因基因于2026年5月21日通过股份回购授权，可回购的股份总数为22,430,020股。美因基因在公告中确认，本次回购已获公司董事会批准，并遵守香港联合交易所有限公司证券上市规则及适用法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因回购600股股份，耗资约4192港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678177831","title":"美因基因(06667)10月27日斥资4192港元回购600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678177831","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678177831?lang=zh_cn&edition=full","pubTime":"2026-10-27 20:20","pubTimestamp":1793103638,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年10月27日斥资4192港元回购600股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170412112","title":"美因基因10月26日回购55,400股，耗资约39.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170412112","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170412112?lang=zh_cn&edition=full","pubTime":"2026-10-26 20:11","pubTimestamp":1793016671,"startTime":"0","endTime":"0","summary":"2026年10月26日，美因基因发布翌日披露报表，宣布于当日于香港联交所回购55,400股普通股，占该公司现有已发行股本约0.0251%。本次回购每股价格介乎港币7.11元至7.16元，累计耗资约港币39.50万元。回购完成后，公司已发行股份总数维持在224,300,200股，其中220,455,400股为流通股，库藏股数量增至3,844,800股。美因基因称，此次回购基于于2026年5月21日通过的回购授权，该授权可回购股份总数为22,430,020股，现已回购3,844,800股，占授权当日已发行股本的约1.7141%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因10月26日回购55,400股，耗资约39.50万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678198729","title":"美因基因(06667)10月26日斥资约39.5万港元回购5.54万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678198729","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678198729?lang=zh_cn&edition=full","pubTime":"2026-10-26 20:10","pubTimestamp":1793016604,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年10月26日该公司斥资约39.5万港元回购5.54万股，回购价格为每股7.11至7.16港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112262211","title":"美因基因10月23日回购7.3万股，涉资约52.48万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112262211","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112262211?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:26","pubTimestamp":1792751160,"startTime":"0","endTime":"0","summary":"2026年10月23日，美因基因有限公司发布公告，披露公司于当日通过香港联交所场内回购普通股7.3万股，占此前已发行股本约0.0331%。本次回购每股价格介于每股港币7.17元至7.21元之间，合计耗资约港币52.48万元。回购完成后，公司已发行普通股由2.205838亿股减少至2.205108亿股，同时库藏股从371.64万股增至378.94万股，合计已发行股本维持在2.243002亿股规模。公司此前已于2026年5月21日获得股东大会通过购回授权，总数为2243.002万股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因10月23日回购7.3万股，涉资约52.48万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677923411","title":"美因基因(06667.HK)10月23日耗资约52.48万港元回购7.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677923411","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677923411?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:22","pubTimestamp":1792750942,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163035591","title":"美因基因回购9.02万股股份，总额约64.62万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163035591","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163035591?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:46","pubTimestamp":1792662376,"startTime":"0","endTime":"0","summary":"2026年10月22日，美因基因有限公司发布公告，披露于当日于香港联交所场内回购合共9.02万股普通股股份，占回购前公司已发行股份总数约0.0409%。股份回购价介乎每股7.155港元至7.17港元，涉及总金额约64.62万港元。此次回购完成后，公司已发行股份数量减少至220,583,800股，库藏股份增至3,716,400股，总发行股份数仍为224,300,200股。公告显示，公司于2026年5月21日通过回购授权，可回购股份数上限为22,430,020股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因回购9.02万股股份，总额约64.62万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677674620","title":"美因基因(06667)10月21日斥资92.5万港元回购13万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677674620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677674620?lang=zh_cn&edition=full","pubTime":"2026-10-21 21:02","pubTimestamp":1792587720,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年10月21日斥资92.5万港元回购13万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137864826","title":"美因基因回购13万股股份，耗资约92.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137864826","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137864826?lang=zh_cn&edition=full","pubTime":"2026-10-21 21:00","pubTimestamp":1792587642,"startTime":"0","endTime":"0","summary":"美因基因于2026年10月21日公告，公司当日通过香港联交所场内回购普通股13万股，约占回购前已发行股份总数的0.0589%。本次回购每股价格介乎每股7.11港元至7.135港元，总涉资约92.50万港元。回购完成后，公司已发行股份总数变动为2.20674亿股，库存股份数增加至362.62万股，合计总股本保持在2.243002亿股。公司回购授权于2026年5月21日获得通过，可回购股份总数为22430020股。公司确认已遵守香港联交所《证券上市规则》及其他适用法律法规。公告由董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因回购13万股股份，耗资约92.50万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136188627","title":"美因基因回购9万股股份，总额约63.83万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136188627","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136188627?lang=zh_cn&edition=full","pubTime":"2026-10-20 21:05","pubTimestamp":1792501551,"startTime":"0","endTime":"0","summary":"美因基因于2026年10月20日发布公告称，当日通过香港联合交易所场内回购普通股股份9万股，占回购前现有已发行股本约0.0407%。每股回购价格介乎7.08港元至7.095港元，总金额约63.83万港元。本次回购完成后，公司已发行股份由220,894,000股减少至220,804,000股，库藏股则从3,406,200股增加至3,496,200股。根据公告，购回授权于2026年5月21日获通过，总回购数为22,430,020股；截至目前，公司已回购3,496,200股。公告由公司董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因回购9万股股份，总额约63.83万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676369691","title":"美因基因(06667.HK)10月20日斥资63.83万港元回购9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676369691","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676369691?lang=zh_cn&edition=full","pubTime":"2026-10-20 21:01","pubTimestamp":1792501318,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676527871","title":"美因基因于10月16日斥资约63.43万港元回购8.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676527871","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676527871?lang=zh_cn&edition=full","pubTime":"2026-10-18 20:00","pubTimestamp":1792324800,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！\n名额有限，手慢无。让我们共赴可持续之约！【点击报名】美因基因（06667）发布公告，于2026年10月16日该公司斥资约63.43万港元回购8.82万股，回购价格为每股7.16至7.195港元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-10-18/doc-inivrzvm6520527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113328448","title":"美因基因回购8.82万股股份，耗资约63.43万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113328448","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113328448?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:52","pubTimestamp":1792144341,"startTime":"0","endTime":"0","summary":"2026年10月16日，美因基因有限公司公布翌日披露报表称，于当日在香港联交所场内回购普通股8.82万股，占回购前已发行股本的约0.0399%。每股回购价格介乎港币7.16港元至7.195港元，总涉资约63.43万港元。回购完成后，公司已发行股份由220,982,200股降至220,894,000股，库藏股由3,318,000股增至3,406,200股，已发行股份总数仍为224,300,200股。公司确认本次回购已获董事会正式授权，并符合香港联交所证券上市规则及相关法律法规。本公告由公司董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购8.82万股股份，耗资约63.43万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675859822","title":"美因基因(06667)10月16日斥资约63.43万港元回购8.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675859822","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675859822?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:42","pubTimestamp":1792143760,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年10月16日该公司斥资约63.43万港元回购8.82万股，回购价格为每股7.16至7.195港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1508378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168816697","title":"美因基因回购8.8万股股份，总额约63.13万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168816697","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168816697?lang=zh_cn&edition=full","pubTime":"2026-10-15 19:01","pubTimestamp":1792062081,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年10月15日发布公告，披露已于同日回购公司股份并将其持作库藏股。此次回购数量为88,000股，相当于该次回购前公司已发行股本约0.0398%。本次回购的价格介乎每股6.91港元至7.19港元，平均价约7.17港元，合共付出价款631,287港元，折合约63.13万港元。回购完成后，公司已发行股份数降至220,982,200股，库藏股数相应增至3,318,000股，合计股本总数仍为224,300,200股。公告显示，公司于2026年5月21日获得购回授权，可回购股份总数为22,430,020股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购8.8万股股份，总额约63.13万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675534262","title":"美因基因(06667)10月14日斥资71.84万港元回购10.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675534262","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675534262?lang=zh_cn&edition=full","pubTime":"2026-10-14 20:57","pubTimestamp":1791982637,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，该公司于2026年10月14日斥资71.84万港元回购10.1万股股份，每股回购价格为7.09-7.125港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108052452","title":"美因基因回购101,000股股份，总额约71.84万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108052452","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108052452?lang=zh_cn&edition=full","pubTime":"2026-10-14 20:56","pubTimestamp":1791982568,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年10月14日公告，回购公司股票101,000股，占当日回购前已发行股份约0.0457%。回购的价格范围介乎每股港币7.09元至7.125元，耗资共718,380港元，折合约71.84万港元。此次回购完成后，公司已发行股份数量由221,171,200股降至221,070,200股，库存股份数量则从3,129,000股增至3,230,000股，总发行股份数维持224,300,200股不变。公司回购授权于2026年5月21日获得通过，可回购股份总数为22,430,020股。公司指出，此次回购已遵守香港联合交易所有限公司证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购101,000股股份，总额约71.84万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129785726","title":"美因基因10月13日回购8.92万股，涉资约62.95万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129785726","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129785726?lang=zh_cn&edition=full","pubTime":"2026-10-13 20:55","pubTimestamp":1791896147,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年10月13日在香港联交所回购普通股8.92万股，占该公司回购前已发行股本约0.0403%。本次回购每股价格介乎每股6.92港元至7.07港元，合计支付金额629,463港元。公司购回授权于2026年5月21日获股东会批准，授权回购总数为22,430,020股。公告显示，截至本次交易后，公司已于香港联交所或其他证券交易所合计回购股份3,129,000股，占授权批复时已发行股本的1.395%。公司确认本次购回已遵守相关上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因10月13日回购8.92万股，涉资约62.95万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675352821","title":"美因基因(06667)10月13日斥资62.95万港元回购8.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675352821","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675352821?lang=zh_cn&edition=full","pubTime":"2026-10-13 20:52","pubTimestamp":1791895936,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年10月13日，该公司斥资62.95万港元回购8.92万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0063},{"period":"1month","weight":0.0086},{"period":"3month","weight":-0.0105},{"period":"6month","weight":0.004},{"period":"1year","weight":0.0067},{"period":"ytd","weight":0.0067}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":-0.0536},{"period":"3month","weight":-0.1001},{"period":"6month","weight":-0.0963},{"period":"1year","weight":-0.1137},{"period":"ytd","weight":-0.0911}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断（IVD）管线产品，包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.166378},{"month":2,"riseRate":0.75,"avgChangeRate":0.055076},{"month":3,"riseRate":0,"avgChangeRate":-0.048593},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.010548},{"month":5,"riseRate":0.666667,"avgChangeRate":0.005636},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.015012},{"month":7,"riseRate":0.5,"avgChangeRate":0.008854},{"month":8,"riseRate":0.25,"avgChangeRate":-0.060544},{"month":9,"riseRate":0,"avgChangeRate":-0.127252},{"month":10,"riseRate":0.25,"avgChangeRate":-0.056658},{"month":11,"riseRate":0.333333,"avgChangeRate":0.114508},{"month":12,"riseRate":0.666667,"avgChangeRate":0.22092}],"exchange":"SEHK","name":"美因基因","nameEN":"MEGA GENOMICS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}